All In Biotech

Drug Trial Radar · NCT03734991

Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis (VANISH 303)

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis

Last checked: Nov 20, 2026Latest source record: Sep 8, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 376 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

376

Actual

Start

Jan 4, 2019

Primary completion

Aug 21, 2019

Study completion Sep 4, 2019

Sponsor

Lead sponsor
Scynexis, Inc.Industry
Sponsor type
Industry
First posted
Nov 8, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 3, randomized, multicenter, double-blind, placebo-controlled study to evaluate the efficacy and safety of oral Ibrexafungerp (SCY-078) compared to placebo in female subjects 12 years and older with AVVC.

Conditions

  • Candida Vulvovaginitis

Interventions

  • IbrexafungerpDrug

    Ibrexafungerp 300 mg BID for 1 day

  • PlaceboDrug

    Matching placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical Cure (Complete Resolution of Signs and Symptoms)Time frame: Day 8-14

Locations

25 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Precision Trials AZ, LLC

    Phoenix, Arizona

  • Womens' Health Care Research Corp

    San Diego, California

  • Women's Medical Research Group

    Clearwater, Florida

  • Altus Research

    Lake Worth, Florida

  • OBGYN Assoc of Mid Florida

    Leesburg, Florida

  • New Age Medical Research Corporation

    Miami, Florida

  • Clinical Trials Management LLC

    Covington, Louisiana

  • Clinical Trials Management LLC

    Metairie, Louisiana

  • Unified Women's Clinical Research- Hagerstown

    Hagerstown, Maryland

  • Wayne State University

    Detroit, Michigan

  • Consultants In Women's Healthcare, Inc.

    St Louis, Missouri

  • Center For Women's Health and Wellness LLC - Interspond - PPDS

    Lawrenceville, New Jersey

  • Lawrence OB/GYN Clinical Research, LLC

    Lawrenceville, New Jersey

  • GYN Center for Women PA

    Durham, North Carolina

  • Carolina Women's Research and Wellness Center

    Durham, North Carolina

  • Unified Women's Clinical Research Greensboro

    Greensboro, North Carolina

  • Unified Women's Clinical Research

    Morehead City, North Carolina

  • Unified Women's Clinical Research Raleigh

    Raleigh, North Carolina

  • Unified Women's Clinical Research - Lyndhurst Clinical Research

    Winston-Salem, North Carolina

  • Medical Research South

    Charleston, South Carolina

  • Magnolia Ob/Gyn Research Center, LLC

    Myrtle Beach, South Carolina

  • Medical Research Center of Memphis

    Memphis, Tennessee

  • TMC Life Research Inc

    Houston, Texas

  • Group For Women

    Norfolk, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.